US2018111930A1PendingUtilityA1
Compositions and uses thereof
Est. expiryApr 3, 2029(~2.7 yrs left)· nominal 20-yr term from priority
Inventors:Dipen DesaiRalph DiodoneZenaida O. GoPrabha N. IbrahimRaman IyerHans-Juergen MairHarpreet K. SandhuNavnit H. ShahGary Conard VisorNicole WyttenbachStephen LauperJohannes PudewellFrank Wierschem
A61P 35/04A61P 43/00A61P 35/02A61P 35/00A61P 25/16A61P 29/00A61P 25/00A61P 25/04A61P 25/28A61P 21/00A61K 9/1652A61K 9/0019C07B 2200/13C07D 471/04A61K 9/0014A61K 31/437A61K 9/10A61K 31/4375A61K 9/1635F01N 13/08F01N 13/1877F01N 13/1888F01N 2470/06F01N 2470/14F01N 2470/16
58
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Provided are solid dispersions, solid molecular complexes, salts and crystalline polymorphs involving propane-1-sulfonic acid {3-[5-(4-chloro-phenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluoro-phenyl}-amide.
Claims
exact text as granted — not AI-modified1 .- 35 . (canceled)
36 . A crystalline polymorph Form 1 of Compound I that exhibits a powder x-ray diffraction pattern having characteristic peak locations of approximately 4.7, 9.4, 11.0, 12.5, and 15.4 degrees 2θ.
37 . A crystalline polymorph according to claim 36 , wherein said polymorph exhibits a powder x-ray diffraction pattern having characteristic peak locations of approximately 4.7, 9.4, 10.0, 11.0, 12.5, 14.2, 15.4, 18.6, and 22.2 degrees 2θ.
38 . A crystalline polymorph according to claim 36 , wherein said polymorph exhibits a powder x-ray diffraction pattern having characteristic peak locations of approximately 4.7, 9.4, 10.0, 11.0, 12.5, 14.2, 15.4, 16.1, 18.6, 19.0, 22.2 and 26.8 degrees 2θ.
39 . A crystalline polymorph according to claim 36 , wherein said polymorph exhibits a powder x-ray diffraction pattern substantially the same as the powder x-ray diffraction pattern of FIG. 1 .
40 . A method according to claim 23 , wherein Compound I is a crystalline polymorph that exhibits a powder x-ray diffraction pattern having characteristic peak locations of approximately 4.7, 9.4, 11.0, 12.5, and 15.4 degrees 2θ.
41 . A purified form of the crystalline polymorph of claim 36 .
42 . A crystalline polymorph Form 2 of Compound I that exhibits a powder x-ray diffraction pattern having characteristic peak locations of approximately 8.8, 9.2, 13.5, 19.1 and 24.4 degrees 2θ.
43 . A crystalline polymorph according to claim 42 , wherein said polymorph exhibits a powder x-ray diffraction pattern having characteristic peak locations of approximately 6.7, 8.8, 9.2, 13.5, 15.0, 17.7, 19.1, 19.7, 21.4 and 24.4 degrees 2θ.
44 . A crystalline polymorph according to claim 42 , wherein said polymorph exhibits a powder x-ray diffraction pattern having characteristic peak locations of approximately 6.7, 8.8, 9.2, 13.5, 14.1, 14.5, 15.0, 16.2, 17.0, 17.7, 19.1, 19.7, 21.4, 22.2, 24.1, 24.4, and 28.1 degrees 2θ.
45 . A crystalline polymorph according to claim 42 , wherein said polymorph exhibits a powder x-ray diffraction pattern substantially the same as the powder x-ray diffraction pattern of FIG. 2 .
46 . A method according to claim 23 , wherein Compound I is a crystalline polymorph that exhibits a powder x-ray diffraction pattern having characteristic peak locations of approximately 8.8, 9.2, 13.5, 19.1 and 24.4 degrees 2θ.
47 .- 53 . (canceled)Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.